Table 1: Clinical data on 31 consecutive patients given chemotherapy through a permanent intraperitoneal port placed prior to the closure of the abdomen.

Gender  Male 16  Female 15 Age  Median 49  Range 32–74 Diagnosis  Peritoneal mesothelioma 19  Appendiceal adenocarcinoma 5  Papillary serous cancer 3  Pancreas cancer 3  Rectal cancer 1 Cytoreduction  Complete or near complete (CC-0/CC-1) 23  Incomplete cytoreduction 8 % of patients completing 5 or more cycles of with adverse events requiring removal of intraperitoneal port  Complete or near complete cytoreduction 9% (2/23)  Incomplete cytoreduction 75% (6/8)